# Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

> **Newsylist Open Intelligence Dossier** · First detected: 2026-06-26 13:21 UTC · Category: Business · Sources: 15 · Current Velocity: 17.43

## Executive Summary
Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.

## Intelligence Brief
The Committee for Medicinal Products for Human Use (CHMP) has recommended pirtobrutinib (Jaypirca) for approval in the European Union. The recommendation covers the treatment of adults with chronic lymphocytic leukemia (CLL) across all lines of therapy.


Coverage from Yahoo Finance, The Pharma Letter, and the European Medicines Agency (EMA) emphasizes the regulatory progress for Jaypirca. Simultaneously, financial outlets such as TIKR.com, Moomoo, and TradingKey report that Eli Lilly stock rose significantly, citing both the EU panel's backing and expanded Medicare access for GLP-1 medications.


Eli Lilly has submitted a marketing authorization application for Jaypirca to the European Commission. Further attention is directed toward the results of the BRUIN CLL-322 trial and the potential for treatment-free remissions.

## Verified Facts & Key Claims
### What was the CHMP's recommendation for Jaypirca?
The CHMP recommended pirtobrutinib (Jaypirca) for EU approval in adults with chronic lymphocytic leukemia (CLL) across all lines of therapy.

### How did Eli Lilly's stock react to the news?
The stock surged, with reports citing gains of 4%, 6.15%, and 7%.

### What other factors contributed to Eli Lilly's stock movement?
Investors are also focusing on obesity franchise momentum and the opening of Medicare access for GLP-1 medications.

## Key People, Organizations & Locations
Eli Lilly, Meeting, U.S Stocks Move, Eli Lilly Shares Jump, Eli Lilly and Co LLY.US Rises Over, Target Means for Investors, Medicare Opens GLP-1 Access What, Eli Lilly Stock Jumps, CHMP Recommends Pirtobrutinib for EU Approval, Medicare GLP-1 Access and Obesity Franchise Momentum

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| TIKR.com | Eli Lilly Stock Jumps 7% as Medicare Opens GLP-1 Access: What a $2,100 Target Means for Investors | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZER3U09sSkJNREc1RjNKeHFDLTZoY2ZHSmY5TktsS1hBLTdvUUtTT3RtZ1hub3NPRTVVVU1VZWZGVXlqQzFQS2NZSTUyaVhMejBTc1NSc25CNlZBM3VlTlJpRWk3bUJJLXl6bUktZXdEODh5VnItSXZ4YnF0RzB6YjZJSjZlczVVeEpzUGY3Yng4SGJGZGYtcDMyazY3NXlOWjE5WS1Zd3M0TkRKWklYaDYwblVpZnlHZjZF?oc=5) |
| 富途牛牛 | U.S. Stocks Move - Eli Lilly and Co (LLY.US) Rises Over 4% as Jaypirca Marketing Authorization Application Submitted to European Commission | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxQdGxpc1NXc1hPV3BmQkxkOEVSY1d1RzZ2SkE1cks1TEZXZnFnaWE1aERzbnkyWTg5NmtTcXM4NGJyaTlfdzM3b1d0WDVCS2FmWlBxcExVNE5qMEFHaldsQ0M0eUp5Q3FsLTU4MmZxRXlXRFpVS0pFMWY5cnJXbHpWY2ZmeVVjUjFOSG9kemQtTlMxRms?oc=5) |
| Investor's Business Daily | Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMigwFBVV95cUxQVHhIQmtMM29iNmNXaVdEWHlZRW5mcVNKT3F5UFFKRVRFLVYzbnB4d0RtZm9DTFlGVU1kOEpreTZEejBiLThHbkxLQk5IVmR4U2RyWm81Vnc0OXpkdzRMZC1oLV9zZkV5amtleGVZbU9nX0FRNFhVX3FNbl9sRDliQlliYw?oc=5) |
| Moomoo | Eli Lilly Shares Jump as Investors Focus on Medicare GLP-1 Access and Obesity Franchise Momentum | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxPbUpoQ2F2aXRXZUFqSzR5cURLLTdwTFdfZTZHNmc4UUhjc2gxMHF0YWFDMmEyb09OUm5MM2F1TFdtYWd6bEZjUk1CM0dZcnNYcG5ZQm5UVDk2cEI5VHBTdXhWVFAzSno2cGp3c0dqZzRZckw1RndZajdjUkxEbThlSmYzTWZoWkExMUdiR3pHMkF6QlFob0RwMDFmMWZLYUE?oc=5) |
| OncLive | CHMP Recommends Pirtobrutinib for EU Approval in CLL Across All Lines of Therapy | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxNSmdNZE01Q2JPd2JmVUNsSjRRYnlrRlQ2NXdVWm9VWXliQzViSDVqelF0dVlZT1EtRUlFTDF2ajBkd012N25LbC1mWXFfMVlGeXl0UTNTTW5jSkZXWHdiQzl6d0FZYmxDSFJXUVh1VlNvalpOTkRieUpiX3RadUY0dk1PLUNROVM3VDdxZTRwcEN0SV80Q0xmM3hXM1AtVlMyRGdWTVk2YVlHcVhrTVE?oc=5) |
| Yahoo Finance | Why Is Eli Lilly (LLY) Stock Soaring Today | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxPWEFSdmxTaXgxejNjdFFwZkdoZkFFWlp0T0FSNnVHWFhHN1hTdnRLZEJzbzJNMi1kSXRRUDhOMzJmMHdfeGttWXRnQ1RUUUZDSnhtV0lKRU1TZTZCUUVGTy1lN2hCZnNkellGUklqVDVhZFlsODFqVGxhbTJBcDJNZXFPSXdYRm5QRkZQbg?oc=5) |
| Investor's Business Daily | Lilly Hits Record High On Massive Profit Growth, Leads 28 Just Added To Best Stock Lists | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxPVldDUWg4NlZSSFhsQ21WUVB0NzRPVnJTTnRXeVRqUl9EUGlNWUJjUDJmbGxkSjdkeDFHdzZBT09EeXdWYTE2TXJZazRYQTZhcDdScDI2NUI1UUVNY1RiSXo3VUxGSFYtZ1FlZXVBT1F2NmpINUpQZS1vRlV1eTg3MjF1YWExVUdUY2tuNmRuN2pIYks5RkQ3b0FQMGQ1akwtTEl5ZlpuUkVUUkZNN3FtNmNtSllRc2sxTzI4?oc=5) |
| Oncology News Central | Pirtobrutinib Plus Venetoclax Shows Promising Results in CLL | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxOZFhBSHRianJGU3FLQU1RUjVLa1hKRmcyT01QcndWWWpRa2pWa0hBVVV6YUduQ0p3bl9nRlJOZFpXVmJYZ1dIRnBoSkVncFVmX3VJSkVoMFlndGhPRUgyd2U3enJuYmJHRmUxZm1WLWpPSktvdkhfb0hkRElYMkNfYVl0UFpOVmZreVFuYnRPM2lzbXAzR1BZS2NnSnZPYnJFRTItY3E2ZEdCbHZneWdPSHhKNy1zUQ?oc=5) |
| The Pharma Letter | June 2026 batch of EMA/CHMP recommendations | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxNbzVGUGdCclR1ZTJUb1BKZEM1eGJaWW9zQ3puRG5ZbG1lU3o4eUV0Z003SEwyRjBmTHVhRHN5bkx5eV9hMGt6dnlwNllCNzN5V1cxSjdicUlWMUhyLWZ1VHZxY0Q4UGJyM3NUdnFkeTZhS0gxb25YUFhxel9YYjJjc0tnMmJ4U01iSWliVmRQWlI?oc=5) |
| The Globe and Mail | Why Is Eli Lilly (LLY) Stock Soaring Today | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxNMUE4VmI1QVhydU52OEpKZVpINWNCQnFzeVYyWUhpZE5vSWU4UUktS2oteHBhUm1Kc2dZd3ZlMktkbkJoSUl6TzBZdmNNSVlyTVR5MW1YUXFjZzZDMlRzWE8zTnNjS1NqMERnWE1XV1RIQmV3MkRUQk5uN2hvTUI0LUk3WGd4aFhrSmtBV3lNb01YZGhHYkdycGFGV3NOTGVCeTl2NmNXZU9RYWZSdTVKZy1pbFpjb1QwbmFHQ3FPdTdaUQ?oc=5) |
| Yahoo Finance | Eli Lilly shares rise after EU panel backs expanded use of Jaypirca | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxQV2Q3MmNBbDdDMWEtMzVPOVk5cmZjTHpJYlBVelhwTkVxbjBPYlVPLXBxX3diRkIwY0tjRGQ3Z2NJSnNYSndiZDktYnFLRXFOMXE5c0hjTkFjY054M29NbG41NW5kMl9uOUp4Zk9PZHp5LTc4cWZRWWltSGc3d1RMZVE1Y2xsUUNhSlkzMkl3?oc=5) |
| Oncodaily | Matthew Davids' Comments on the New Phase 3 Results From the BRUIN CLL-322 Trial - Dana-Farber | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiW0FVX3lxTFBsdmZpLWZoYWNVU3VzT2RpeGZFOGQ4ZFdUZTZLN3F3RFBuZ2huTC1rOEwyNUdVNWNnN3g0bEc1eHdESkhDd3I4QnVUUl95dTdhd1lwaUp3QnMwR3c?oc=5) |
| GuruFocus | Eli Lilly (LLY) Gains EMA Support for Cancer and Diabetes Treatm | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxPXzNxeWFCVy1kY0ozeWNReGFINk5TZlNWOGMtMk1SdmpBcWxQa3FlSDdaX2IwTjRvbXZKaV80RWFWZDVrcGtEM0oxdXlaMlZhOGoxdVZ6YmU5LW5GNXNEcTdfaXl3cFJSc2d3RDlmdDVLZEhIb1RsSjVES2pMVmE2YU5wakRWaWtCTUM3UEUxcElPa1FaeXFQcmJNbmU4dTh0OWlXc0RhV00?oc=5) |
| TradingKey | Eli Lilly and Co Stock (LLY) Moved Up by 6.15% on Jun 26: Drivers Behind the Movement | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxORmFBcThJYzFyaW4wWHc2MDJIS0MwQzQ0UG1IS2pEdHZLckxqVzJMRmxCMUs3cXktV3JTYUtGWEllTFVvWlE5QzZCTmRWbkhsZ3RDbGFtaUtXMFhaWklodkdXWHR2eEJMdW85VU9fYnJheEtXbGplckw2VTJ0ek90U01MQWs1VEdabFE?oc=5) |
| Targeted Oncology | Dr Ahn: Exploring Treatment-Free Remissions With Pirtobrutinib in CLL | 2026-06-26 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxOOUE2R2pfcXJmVTRGYTNGa0FCNTlJMm9kTk1ZS1MtbWg1UnN4Rlh6YVl4MlpEVEdrY2duRmpQcndDbTBkeGV1Yzh5QnRJeVRsYXJhMExVRXB3NVk1MG1LaWRFUm9aSUlFN3RKYnN3YUg3MDhLOGNSZGRQZVUzMjdWMFZqQUdNRUdqYnVWdmp5clpfdVZ0TjBEb0U4ai05SUZMRUdr?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-06-26/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*